Back to Top Skip to main content Skip to sub-navigation

COVID-19 leads to innovation in military health care practices

Man in lab coat and mask prepares sample for COVID-19 testing. Army Spc. David Pyke, medical laboratory technician, loads a patient sample for rapid COVID-19 polymerase chain reaction testing at Brooke Army Medical Center, Fort Sam Houston, Texas, April 9, 2020. (U.S. Army photo by Jason W. Edwards)

Recommended Content:

Coronavirus | Research and Innovation

The arrival of the novel coronavirus brought many challenges to the health care community. Doctors, researchers, and policymakers around the world had to face the virus and determine the best ways to keep their communities safe. This discussion and collaboration resulted in many medical practice and policy innovations. The military is no exception. Health care professionals throughout the Military Health System worked together to address the new normal, changing how care should be brought to patients worldwide.

U.S. Assistant Secretary of Defense for Health Affairs Thomas McCaffery iterated that innovation in the MHS supports the Department of Defense's priorities in COVID-19: protect the workforce, maintain military readiness, and support the national response.

“The Military Health System is serving on the frontlines against this invisible enemy,” McCaffery said, “bringing all that we have to bear across our military medical expertise, research and development, and our far-reaching, world-class system of health care and military medical combat support capabilities."

Each category McCaffery mentioned supports patient-centered care. With the quick spread of the novel coronavirus and COVID-19, hospitals and clinics found creative ways to care for patients while preventing spread of the disease. Inventive practices like drive-up pharmacies and immunization clinics allowed patients to continue receiving medication without having to set foot in the hospital. MHS expedited COVID-19 and flu test results to help patients take action quickly if their results came back positive.

Many hospitals also increased their telehealth capabilities, caring for patients over the phone or via video call when they could. Channels like the MHS Nurse Advice Line saw a higher call volume in the initial rush of the pandemic. The Defense Health Agency even made temporary changes to telehealth regulations so patients could enjoy more access to telehealth services, and health care providers could expand their reach to provide it.

Soldier leaning into car
The fight against the novel coronavirus forced military health care professionals to get creative with ways to safely provide care to patients. Innovative practices like the drive-thru pharmacy at Joint Base San Antonio-Lackland, Texas, help providers give this care while working to reduce the spread of COVID-19. (Photo by Senior Master Sgt. Robert Shelley)

Within hospitals, unique problems arose that required solutions. A team from Keesler Air Force Base in Biloxi, Mississippi, prototyped a proning shelf to help COVID-19 patients suffering from acute respiratory distress syndrome breathe easier. Scientists and engineers at Naval Surface Warfare Center Panama City Division developed low-cost, easily-assembled ventilators as part of the DoD Hack-a-Vent Innovation Challenge. Once FDA-approved, these ventilators can be rapidly prototyped and used to support critical care requirements like complications from COVID-19 in hospital and field settings around the world.

Clinical and inpatient pharmacists at William Beaumont Army Medical Center in El Paso, Texas, collaborated with nursing to change how they administer medicine to patients by bundling medications. They adjusted dosing times to align with meal delivery schedules, morning labs, or vital sign checks as much as possible while maintaining safety and efficacy of the medications. This prevents frequent comings and goings in patients' hospital rooms. In doing so, exposure to both patients and staff is minimized. Critical personal protective equipment is also preserved.

Providers were aided by DoD and the Department of Veterans Affairs launching the joint health information exchange. This electronic exchange helps medical professionals safely and securely access patient health information and medical records, and share it as necessary to provide care. The JHIE supports more informed decision-making for the health care of service members, veterans, and family members, regardless of where patients access care.

DHA also gathered experts from the field to create a tri-service Infection Prevention and Control Tiger Team. The IPC Tiger Team provides evidence-based answers about COVID-19 to roughly 475 military hospitals, medical clinics, and dental clinics within the MHS.

As hospital and clinic operations changed to meet new challenges, the MHS required more boots on the ground to provide health care to patients. Military hospitals in New York City and Los Angeles quickly reached capacity to treat patients with COVID-19, so DoD deployed hospital ships, USNS Comfort to New York and USNS Mercy to Los Angeles for medical support. In addition, National Guard reservists answered the call to help staff overwhelmed hospitals in New York City.

Medical students at the Uniformed Services University for Health Sciences also stepped up to staff hospitals. USU adjusted coursework for its students to learn more about COVID-19, and many of those students graduated early to support the MHS as doctors and nurses.

While hospitals staffed up on the front end, the country still needed to find a vaccine on the back end. MHS professionals in research and development aid in the quest for a vaccine. Researchers at DHA’s Joint Pathology Center added their expertise to the mix to help health care providers better understand COVID-19. JPC studies tissue samples under the microscope, showing patterns that emerge from the damage that the respiratory virus leaves in the human body.

New approaches to genome sequencing have been critical to this equation. The Global Emerging Infections Surveillance section of DHA’s Armed Forces Health Surveillance Branch used existing partnerships with Army, Navy, and Air Force public health and medical research laboratories to research genome sequencing. The team worked together to create a collaborative approach to sequencing the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, genome. This virus strain causes COVID-19.

The Air Force Genetics Center of Excellence at Keesler AFB also conducted research with DoD partners into sequencing SARS-CoV-2. Through these partnerships, DoD researchers gained the ability to isolate the virus, share samples, and compare laboratory methods to improve genome sequencing capabilities.

Although many strides have been made to combat the novel coronavirus, there is still room for innovation. The expansion of telework capabilities in response to the national emergency may become a part of the “new normal.” Research into convalescent plasma from patients who have contracted and recovered from COVID-19 can help researchers develop an effective treatment for the disease.

The MHS stands ready to continue innovating to provide quality health care to its beneficiaries throughout the armed forces and support the safety of the nation.

“We remain focused on supporting the Department in this complex and challenging environment with the best that military medicine has to offer,” McCaffery said. “We are proudly continuing to deliver on that obligation.”

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA-PI 3200.01: Research and Development (R&D) Enterprise Activity (EA)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): a. Establishes the Defense Health Agency’s (DHA) procedures for the Deputy Assistant Director (DAD), R&D to manage and execute, on behalf of the Assistant Secretary of Defense for Health Affairs (ASD(HA)), the portion of the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation assigned to it (referred to as the “DHP Science and Technology (S&T) Program)”. The DHP S&T Program includes Budget Activities (BAs) 6.1-6.3 and 6.6. The ASD(HA) provides policy, direction, and guidance to inform planning, programming, budgeting, and execution of the DHP RDT&E appropriation in accordance with statute, regulation, and policy in Reference (a). The DAD-R&D, and Component Acquisition Executive (CAE) manage and execute DHP RDT&E Program funds aligned to them on behalf of the ASD(HA). The CAE is responsible for managing BAs 6.4, 6.5, and 6.7 funding, as well as Procurement and Operations and Maintenance funding required to support DHP-funded Acquisition Programs, regardless of acquisition activity. b. Supports the Director, DHA, in developing appropriate DHA management models to maximize efficiencies in the management and execution of DHP RDT&E-funded activities carried out by the Combatant Commands (CCMDs), Services, Uniformed Services University of the Health Sciences (USU), Defense Agencies, and other DoD Components, as applicable. c. Codifies processes to confirm DHP RDT&E funds are applied towards medical priorities and aligned to ASD(HA) policy, direction, and guidance to develop and deliver innovative medical products and solutions that increase the readiness of the DoD medical mission in accordance with Reference (a). d. Supports the following objectives of the R&D EA: (1) Increasing the quantity, quality, and pace of medical research through improved programmatic organization, processes, and oversight. (2) Ensuring DHP RDT&E funded efforts align to ASD(HA) published program guidance that provides resourcing guidance and translates national, departmental, and Service priorities into specific program objectives. (3) Verifying alignment of DHP RDT&E funds to medical priorities and to ASD(HA) policy, direction, and guidance to ensure the development and delivery of medical materiel and knowledge solutions. (4) Facilitating coordination with the CCMDs, Services, USU, Defense Agencies, and other DoD Components, as applicable, to ensure DHP RDT&E funded activities address joint medical capability gaps, and avoid unnecessary duplication.

Guidance on the Establishment of a Human Cell, Tissue, and Cellular and Tissue Based Products Program

Policy

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

Showing results 1 - 12 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.